CDH2 and gastric cancer: Luteolin application caused a reversion of EMT via shrinkage in the cytoskeleton and increment in the expression of epithelial biomarker E-cadherin and downregulation of the mesenchymal biomarkers N-cadherin, vimentin, and Snail in gastric cancer cells.